Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 11 » Issue 1

The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® study)

Total article views   Abstract views HTML views PDF downloads Totals
18,451 Dovepress* 11,692 2,304+ 2,144 13,996
PubMed Central* 0 4,455 2,078 4,455
Totals 11,692 6,759 4,222 18,451
*Since 3 February 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
7 0 0 0 2 5

View citations on PubMed Central and Google Scholar